our stories - Fatty Liver Foundation

In Memoriam
What is my risk?
Disease Stages
Food
- Diet Information
- Food articles
Voices our blogs
Wellness Ambassador
- wellness league search
- Ambassador Donation Portal
noninvasive tests
- noninvasive basic
- LIVERFASt
- NIS4
- FIB-4 Index
- APRI
- ELF
- FibroScan
- Velacur
SCIENCE
Projects
RESOURCES
Press
Sponsors
ABOUT
COVID-19 info
- covid-resources
- covid-medical
drug_pipeline

WISH I HAD KNOWN

NASH EDUCATIONAL VIDEOS

AT RISK?

Overweight?
Failed to Lose Weight?
NASH Overview

FATTY LIVER

Overview NAFLD
1 in 3 Have It
Diet

NAFLD

Overview
Symptoms
Should I Be Scared?
Diet

NASH

Overview
Symptoms
Diet
NASH Education Program

CIRRHOSIS

Overview
End Stage Liver Disease
Multiple Listing
Living Donors
Become a Donor

Diet Information

Liver Friendly Diet
SIMPLEST DIET ADVICE
COMPARE Diets
NAFLD Diet
NASH Diet
HEALTHY Diet

Food articles

QUICK EATING VIDEOS
Olive Oil
Sugar
Coffee
Salt
Omega 3
Triglycerides
Liver Cleanses - Helpful?
Supplements useful?
Supplements NOT
Apollo Olive Oil

Foundation blog

Patient Stories

Caregiver Stories

Sarah Larsen

wellness league search

Ambassador Donation Portal

noninvasive basic

LIVERFASt

NIS4

FIB-4 Index

APRI

ELF

FibroScan

Velacur

Basic Liver Facts

Science Behind Diet

Right Upper Quadrant (RUQ) Pain

SCREENING PROJECT

Big Picture
Pilot Project
Project Overview
National Fatty Liver Registry
Medical Facts
SUNN Study

Webinars

LIVER Webinar Series
Wellness Webinars

The State of NAFLD/NASH Care in America

2022 Findings
2023 Findings

How To Help

DONATE
NETWORK FOR GOOD
PayPal
Donate Your Change

Clincal Trial Overview

Healthwell Financial Assistance

Newsletter Sign-Up

Blow A Kiss

CBD

HIGADOGRASO

FLF Launches a Public-Private Partnership to Combat the Silent Epidemic of NAFLD

FLF and Fibronostics form a patient education partnership

Gabriella Wan joins FLF

FLF Appoints New Chief Financial Officer

Echosens Aligns with FLF to Accelerate Screening for Undiagnosed NAFLD and NASH

SUNN-1 Recruitment Complete

At Mexican Consulate

EASL 2019

Press FAQ --- Fatty Liver Foundation

Dancing with the Dark Angel

Kiss and Click Challenge

Dr Charlton, lifesaver

Searching for a cure

GE Reports MRI Elastography

Living with cirrhosis

Silent killer stalks 100 million

Skydiving Granny fights depression

Fatty Liver Foundation Launches the State of NAFLD/NASH Care in America ™ Initiative to Support Improved Patient Care Experience

FATTY LIVER FOUNDATION TO MARK INTERNATIONAL NASH DAY WITH THREE INTERACTIVE PROGRAMS OFFERING INFORMATION, INSPIRATION, AND SUPPORT FOR PEOPLE AT-RISK OF OR LIVING WITH NAFLD/NASH

FATTY LIVER FOUNDATION’S ANNUAL NATIONAL SURVEY AIMS TO RESHAPE NAFLD/NASH CARE IN THE U.S.

FATTY LIVER FOUNDATION EXPRESSES CONCERNS ABOUT ICER’S EVIDENCE REPORT ON NASH TREATMENTS

Pivotal FDA Advisory Committee Meeting: Fatty Liver Foundation Advocates for Approval of Groundbreaking NASH Treatment

Fatty Liver Foundation Partners With Secure AI Labs To Empower NAFLD and NASH Community With New Patient-Facing Tool

Shining a Spotlight and Taking Action for Liver Health: Fatty Liver Foundation Marks International NASH Day

Fatty Liver Foundation Celebra el Día Internacional de la EHNA (Esteatohepatitis No Alcohólica)

Fatty Liver Foundation and Society for Sober Liver Survival Forge Groundbreaking Collaboration in the Fight Against Liver Diseases

Sponsorship

In Kind Donations

fibronostics

Geneva Eskridge

Intercept Pharmaceuticals

Echosens

link2labs

madrigal

Galectin

About FLF

My Story
How to Help
Management
Non-Profit 501(c)
Idaho Registration
Mission
Disclaimer
Privacy Policy
Contact Us
Medical Advisory Board

Community Action

EASL 2019 press kit

Learn About FLF

Jobs & Internships

covid-resources

Optional email code

donate now The Fatty Liver Foundation

In Memoriam
What is my risk?
Disease Stages
Food
- Diet Information
- Food articles
Voices our blogs
Wellness Ambassador
- wellness league search
- Ambassador Donation Portal
noninvasive tests
- noninvasive basic
- LIVERFASt
- NIS4
- FIB-4 Index
- APRI
- ELF
- FibroScan
- Velacur
SCIENCE
Projects
RESOURCES
Press
Sponsors
ABOUT
COVID-19 info
- covid-resources
- covid-medical
drug_pipeline

WISH I HAD KNOWN

NASH EDUCATIONAL VIDEOS

AT RISK?

Overweight?
Failed to Lose Weight?
NASH Overview

FATTY LIVER

Overview NAFLD
1 in 3 Have It
Diet

NAFLD

Overview
Symptoms
Should I Be Scared?
Diet

NASH

Overview
Symptoms
Diet
NASH Education Program

CIRRHOSIS

Overview
End Stage Liver Disease
Multiple Listing
Living Donors
Become a Donor

Diet Information

Liver Friendly Diet
SIMPLEST DIET ADVICE
COMPARE Diets
NAFLD Diet
NASH Diet
HEALTHY Diet

Food articles

QUICK EATING VIDEOS
Olive Oil
Sugar
Coffee
Salt
Omega 3
Triglycerides
Liver Cleanses - Helpful?
Supplements useful?
Supplements NOT
Apollo Olive Oil

Foundation blog

Patient Stories

Caregiver Stories

Sarah Larsen

wellness league search

Ambassador Donation Portal

noninvasive basic

LIVERFASt

NIS4

FIB-4 Index

APRI

ELF

FibroScan

Velacur

Basic Liver Facts

Science Behind Diet

Right Upper Quadrant (RUQ) Pain

SCREENING PROJECT

Big Picture
Pilot Project
Project Overview
National Fatty Liver Registry
Medical Facts
SUNN Study

Webinars

LIVER Webinar Series
Wellness Webinars

The State of NAFLD/NASH Care in America

2022 Findings
2023 Findings

How To Help

DONATE
NETWORK FOR GOOD
PayPal
Donate Your Change

Clincal Trial Overview

Healthwell Financial Assistance

Newsletter Sign-Up

Blow A Kiss

CBD

HIGADOGRASO

FLF Launches a Public-Private Partnership to Combat the Silent Epidemic of NAFLD

FLF and Fibronostics form a patient education partnership

Gabriella Wan joins FLF

FLF Appoints New Chief Financial Officer

Echosens Aligns with FLF to Accelerate Screening for Undiagnosed NAFLD and NASH

SUNN-1 Recruitment Complete

At Mexican Consulate

EASL 2019

Press FAQ --- Fatty Liver Foundation

Dancing with the Dark Angel

Kiss and Click Challenge

Dr Charlton, lifesaver

Searching for a cure

GE Reports MRI Elastography

Living with cirrhosis

Silent killer stalks 100 million

Skydiving Granny fights depression

Fatty Liver Foundation Launches the State of NAFLD/NASH Care in America ™ Initiative to Support Improved Patient Care Experience

FATTY LIVER FOUNDATION TO MARK INTERNATIONAL NASH DAY WITH THREE INTERACTIVE PROGRAMS OFFERING INFORMATION, INSPIRATION, AND SUPPORT FOR PEOPLE AT-RISK OF OR LIVING WITH NAFLD/NASH

FATTY LIVER FOUNDATION’S ANNUAL NATIONAL SURVEY AIMS TO RESHAPE NAFLD/NASH CARE IN THE U.S.

FATTY LIVER FOUNDATION EXPRESSES CONCERNS ABOUT ICER’S EVIDENCE REPORT ON NASH TREATMENTS

Pivotal FDA Advisory Committee Meeting: Fatty Liver Foundation Advocates for Approval of Groundbreaking NASH Treatment

Fatty Liver Foundation Partners With Secure AI Labs To Empower NAFLD and NASH Community With New Patient-Facing Tool

Shining a Spotlight and Taking Action for Liver Health: Fatty Liver Foundation Marks International NASH Day

Fatty Liver Foundation Celebra el Día Internacional de la EHNA (Esteatohepatitis No Alcohólica)

Fatty Liver Foundation and Society for Sober Liver Survival Forge Groundbreaking Collaboration in the Fight Against Liver Diseases

Sponsorship

In Kind Donations

fibronostics

Geneva Eskridge

Intercept Pharmaceuticals

Echosens

link2labs

madrigal

Galectin

About FLF

My Story
How to Help
Management
Non-Profit 501(c)
Idaho Registration
Mission
Disclaimer
Privacy Policy
Contact Us
Medical Advisory Board

Community Action

EASL 2019 press kit

Learn About FLF

Jobs & Internships

covid-resources

Real Stories About Real People

Do you like this page?

Tweet

Click for our online community

Sign in with:

Or sign up:

Optional email code

Fatty Liver Foundation copyright 2023 all rights reserved

www.fattyliverfoundation.org

The information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information should not be used as a substitute for professional diagnosis or treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. The Fatty Liver Foundation, its officers or contributors expressly disclaim responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site.

connect

get updates

Optional email code

Follow @LiverSaver on Twitter

Sign in with Facebook, Twitter or email.

Created with NationBuilder
using a public theme by cStreet